XAAV

Serial Number 79342692
602

Registration Progress

Application Filed
Feb 28, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
79342692
Filing Date
February 28, 2022
Abandonment Date
August 14, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Aug 30, 2023
Classes
001 005 042

Rights Holder

Oxford Genetics Ltd

99
Address
Medawar Centre,
Robert Robinson Avenue Oxford OX4 4HG
GB

Ownership History

Oxford Genetics Ltd

Original Applicant
99
GB

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

24 events
Date Code Type Description
Feb 14, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Sep 20, 2024 FINT P FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 2, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Aug 31, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 11, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 22, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 31, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 30, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 30, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 6, 2023 RFNT P REFUSAL PROCESSED BY IB
Feb 13, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 13, 2023 RFRR P REFUSAL PROCESSED BY MPU
Jan 12, 2023 LIMN I LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 12, 2023 LIME X LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Dec 17, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 16, 2022 CNRT R NON-FINAL ACTION WRITTEN
Dec 12, 2022 DOCK D ASSIGNED TO EXAMINER
Dec 3, 2022 LIMG M LIMITATION OF GOODS RECEIVED FROM IB
Nov 19, 2022 LIMG M LIMITATION OF GOODS RECEIVED FROM IB
Jun 21, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Jun 17, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 001
Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes; none of the aforesaid being or including cell growth media
Class 005
Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use; none of the aforesaid being or including cell growth media
Class 042
Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services; none of the aforesaid services relating to cell growth media

Classification

International Classes
001 005 042